AEON — AEON Biopharma, Inc.
$0.2399+2.65%
Last close: · regular session
After-hours $0.2415 +0.67% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for AEON in the TickerWise workspace.
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: AMEX
- Employees: 5
- Website: http://www.aeonbiopharma.com
Latest SEC filings for AEON
- 8-K
- 3
- SCHEDULE 13G
- SCHEDULE 13G
- S-1MEF
- EFFECT
- S-1/A
- S-1
- 8-K
- 8-K
Latest AEON news
- AEON Launches Agentic Checkout V2, Bringing AI-Powered Travel Booking to Travala Read article
- AEON Adds Chilean Bank Transfers to Its Global Settlement Network for AI Commerce Read article
- AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450 Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.